Date : Wednesday, 28 October 2026
Start Time : 14:00
End Time : 17:00
Location : Aban
Coagulation Panel
Chair
Salarvand Samaneh
Presentations
14:00 | Introduction, Panel Member Introductions, Importance Of Coagulation Tests In The Laboratory, & Presentation Of The First Scenario
Cu
14:10 | Common Anticoagulant Drugs In Iran & Their Classification Based On Mechanism Of Action & Clinical Use
Cu
14:20 | Anticoagulant Drug Level Monitoring Tests: Indications & Associated Challenges
Cu
14:35 | The Impact Of Pre-analytical Variables On The Accuracy Of Coagulation Tests & Therapeutic Monitoring
Cu
14:50 | Monitoring Therapy With PT, PTT: Key Points, Inter-Kit Differences, & Standardization Of Results
Cu
15:10 | Clinical & Laboratory Approach To Heparin & Warfarin Resistance Cases, & Clinical Decision-Making
Cu
15:25 | Indications & Applications Of Monitoring With The Anti-Xa Test, Including Kit Differences & Interpretation Points
Cu
15:35 | Role Of Point-of-Care Testing Methods In Evaluating & Monitoring Coagulation Tests
Cu
15:45 | Presenting A Scenario About Neonatal Coagulation Tests
Cu
15:50 | Interpretation Of Coagulation Tests In Newborns & Young Children: Challenges, Indications, & Age-Dependent Reference Ranges
Cu